バイオマーカーの世界市場：製品、種類、用途、疾病、地域別分析...市場調査レポートについてご紹介

1 Introduction (Page No. – 9)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered in the Report
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 12)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Assumptions for the Study

3 Executive Summary (Page No. – 19)

4 Premium Insights (Page No. – 24)
4.1 Lucrative Opportunities in the Global Biomarkers Market
4.2 Life Cycle Analysis, By Region

5 Market Overview (Page No. – 28)
5.1 Introduction
5.2 Market Segmentation
5.2.1 By Product
5.2.2 By Type
5.2.3 By Application
5.2.4 By Disease Indication
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Healthcare Expenditure
5.3.1.2 Increase in R&D Funding
5.3.1.3 Increasing Utility of Biomarkers for Diagnostic Purposes
5.3.1.4 Increase in Number of Cros and Low Cost for Conducting Clinical Trials in Developing Countries
5.3.1.5 New Initiatives for Biomarker Research
5.3.2 Restraints
5.3.2.1 High Capital Investment & Low Benefit-Cost Ratio
5.3.2.2 Poorly Suited Regulatory and Reimbursement Systems
5.3.2.3 High Cost of Tests
5.3.2.4 Technical Issues Related to Sample Collection and Storage
5.3.3 Opportunities
5.3.3.1 Personalized Medicine
5.3.3.2 Companion Diagnostics
5.3.3.3 Emerging Economies
5.3.3.4 High Prevalence of Cancer
5.3.4 Challenges
5.3.4.1 Proving Clinical Validity and Utility of Biomarkers-Based Tests

6 Biomarkers Market, By Products (Page No. – 42)
6.1 Introduction
6.2 Consumables
6.3 Services
6.4 Software

7 Biomarkers Market, By Type (Page No. – 50)
7.1 Introduction
7.2 Safety Biomarkers
7.3 Efficacy Biomarkers
7.3.1 Predictive Biomarkers
7.3.2 Surrogate Biomarkers
7.3.3 Pharmacodynamic Biomarkers
7.3.4 Prognostic Biomarkers
7.4 Validation Biomarkers

8 Biomarkers Market, By Application (Page No. – 65)
8.1 Introduction
8.2 Diagnostics Development
8.3 Drug Discovery and Development
8.4 Personalized Medicine
8.5 Disease Risk Assessment
8.6 Other Applications

9 Biomarkers Market, By Disease Indication (Page No. – 76)
9.1 Introduction
9.2 Cancer
9.3 Cardiovascular Disorders
9.4 Neurological Disorders
9.5 Immunological Disorders
9.6 Other Diseases

10 Biomarkers Market, By Region (Page No. – 89)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 133)
11.1 Introduction
11.2 Market Share Analysis, Biomarkers Market
11.3 Competitive Situation and Trends
11.3.1 Acquisitions
11.3.2 Agreements, Collaborations, Expansion, Joint Ventures, and Partnerships
11.3.3 New Product and Service Launches
11.3.4 Other Developments

12 Company Profiles (Page No. – 141)
12.1 Introduction
12.2 Bio-Rad Laboratories, Inc.
12.2.1 Business Overview
12.2.2 Product Offerings
12.2.3 Recent Developments
12.2.4 MnM View
12.3 EKF Diagnostics Holdings, Inc.
12.3.1 Business Overview
12.3.2 Product Offerings
12.3.3 Recent Developments
12.3.4 MnM View
12.4 ENZO Biochem, Inc.
12.4.1 Business Overview
12.4.2 Product Offerings
12.4.3 Recent Developments
12.4.4 MnM View
12.5 Merck & Co, Inc.
12.5.1 Business Overview
12.5.2 Product & Services
12.5.3 Recent Developments
12.5.4 MnM View
12.6 Perkinelmer, Inc.
12.6.1 Business Overview
12.6.2 Products and Services
12.6.3 Recent Developments
12.6.4 MnM View
12.7 Qiagen N.V.
12.7.1 Business Overview
12.7.2 Product Offerings
12.7.3 Recent Developments
12.7.4 MnM View
12.8 Biosims Technologies
12.8.1 Business Overview
12.8.2 Product Offerings
12.8.3 Recent Developments
12.9 Cisbio Bioassays
12.9.1 Business Overview
12.9.2 Products and Services
12.9.3 Recent Developments
12.10 Meso Scale Diagnostics, LLC.
12.10.1 Business Overview
12.10.2 Products and Services
12.10.3 Recent Developments
12.11 Signosis, Inc.
12.11.1 Business Overview
12.11.2 Product Offerings
12.11.3 Recent Developments
12.12 Singulex, Inc.
12.12.1 Business Overview
12.12.2 Products and Services
12.12.3 Recent Developments

13 Appendix (Page No. – 170)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Other Developments
13.4 Introducing RT: Real Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports